Abstract:Chemodynamic therapy as a novel type of chemotherapies can damage the DNA structures and induce cell apoptosis and immunogenic cell death (ICD) through generating reactive oxygen species (ROS) to aggravate oxidative stress. Nonetheless, as an intrinsic antioxidative response of tumor cells, the expression of glutathione (GSH) can be upregulated to maintain the cellular redox balance and protect the tumor cells from ROS-mediated damage. In this context, it is feasibly to simultaneous boost ROS generation and GSH depletion in tumor cells, however, the precise delivery and release of GSH scavengers at specitic subcellular sites is of great importance. Herein, we propose a GSH-responsive mesoporous organosilica nanoparticles (MONs)-based nanomedicine MON-CA-TPP@HA through sequentially covalently attaching Triphenylphosphine (TPP) and electrostatic coating hyaluronic acid (HA) onto the surface of cinnamaldehyde (CA) loaded MONs, known as MON-CA-TPP@HA, which has been demonstrated to be an extremely effective therapeutic strategy for cancer treatment through inducing ICD and apoptosis of breast cancer cells. Systematic in vitro experimental results clearly revealed that the nanomedicines can actively target the tumor cells with the help of HA, subsequently entering the tumor cells, and precisely binding with the mitochondria through TPP residues. Upon the cleavage of the disulfide bond in the MONs triggered by over-expressed GSH within tumor, the CA molecules can be released and induce the excessive ROS in situ surrounding the mitochondria to activate oxidative stress to induce apoptosis and ICD of breast cancer cells. The results in vivo experiments confirm that the MON-CA-TPP@HA nanomedicine can effectively promote DCs maturation, CD 8+ T cells activation, and improve the ratio of M1/M2 macrophages which improve tumor immunosuppressive microenvironment. It is thus believed that the current nanomedicines have paved a new way for the future cancer therapy.

Zeolitic imidazolate framework-based nanoparticles for the cascade enhancement of cancer chemodynamic therapy by targeting glutamine metabolism

Bioinspired nanocatalytic tumor therapy by simultaneous reactive oxygen species generation enhancement and glutamine pathway-mediated glutathione depletion

ATP-triggered Mitochondrial Cascade Reactions for Cancer Therapy with Nanoscale Zeolitic Imidazole Framework-90

Mitochondrial Dysfunction and Antioxidation Dyshomeostasis-Enhanced Tumor Starvation Synergistic Chemotherapy Achieved Using a Metal-Organic Framework-Based Nano-Enzyme Reactor.

Nanoparticle-Mediated Inhibition of Mitochondrial Glutaminolysis to Amplify Oxidative Stress for Combination Cancer Therapy

Nanoscale Dual-Enzyme Cascade Metal-Organic Frameworks Through Biomimetic Mineralization As ROS Generators for Synergistic Cancer Therapy.

A Biodegradable Nanodrug with Highly Efficient Treatment Effect by Remodeling Tumor Microenvironment and Manipulating Energy Metabolism Against Colorectal Cancer

Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy

Boosting Chemodynamic Therapy by Tumor-Targeting and Cellular Redox Homeostasis-Disrupting Nanoparticles.

Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer by inhibition of glutamine metabolism

A drug ligand based bimetallic coordination-driven self-assembly nanodrug for high-efficiency tumor chemodynamic therapy

Tumor-targeted delivery of hyaluronic acid/polydopamine-coated Fe2+-doped nano-scaled metal-organic frameworks with doxorubicin payload for glutathione depletion-amplified chemodynamic-chemo cancer therapy

Glutathione-sensitive Mesoporous Nanoparticles Loaded with Cinnamaldehyde for Chemodynamic and Immunological Therapy of Cancer

Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy

Engineering of a double targeting nanoplatform to elevate ROS generation and DSF anticancer activity

Manganese Self-boosting Hollow Nanoenzymes with Glutathione Depletion for Synergistic Cancer Chemo-chemodynamic Therapy

A Glutathione-Consuming Bimetallic Nano-Bomb with the Combination of Photothermal and Chemodynamic Therapy for Tumors: An in vivo and in vitro Study

Biodegradable nanotherapeutic with simultaneously GSH depletion and H 2 O 2 supplying for enhanced synergistic chemotherapy/chemodynamic therapy

Cuprous oxide-based nanocrystals with combined chemo/chemodynamic therapy to increase tumor drug sensitivity by reducing mitochondria-derived adenosine-triphosphate

Cu-MOF chemodynamic nanoplatform via modulating glutathione and H2O2 in tumor microenvironment for amplified cancer therapy

ATP-responsive copper(II)-doped ZIF-nanoparticles for synergistic cancer therapy: combining cuproptosis and chemo/chemodynamic therapy